Akèy › Limfom Selil-T › Pennsylvania › Philadelphia
Etid klinik pou Limfom Selil-T nan Philadelphia, PA
10 etid pou Limfom Selil-T ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Ap rekriteFaz 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Ap rekriteEtid obsèvasyon
- Children's Hospital of Philadelphia, Philadelphia
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Ap rekriteFaz 1/2
- University of Pennsylvania, Philadelphia
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
Ap rekriteFaz 3
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi lwen
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mi lwen
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Ap rekriteFaz 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
CD45BE-HSPC + CART-45 Cells
Ap rekriteFaz 1
- University of Pennsylvania, Philadelphia
Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma
Ap rekriteFaz 1
- Children's Hospital of Philadelphia, Philadelphia
A Registry for People With T-cell Lymphoma
Ap rekriteEtid obsèvasyon
- University of Pennsylvania (Data Collection Only), Philadelphia
- Thomas Jefferson University Hospital (Data collection only), Philadelphia
CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)
Ap rekriteFaz 1
- University of Pennsylvania - Abramson Caner Center, Philadelphia
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Ap rekriteFaz 1
- Children's Hospital of Philadelphia, Philadelphia
Etid Limfom Selil-T nan lòt vil
- New York City, NY13 etid
- Baldwin Park, CA9 etid
- Boston, MA9 etid
- Houston, TX8 etid
- Atlanta, GA8 etid
- Rochester, MN6 etid
- Columbus, OH6 etid
- Chicago, IL6 etid
- Seattle, WA6 etid
- New Haven, CT5 etid
- Miami, FL5 etid
- Scottsdale, AZ4 etid
Lòt etid nan Philadelphia
- Kansè (tout kalite)59 etid
- Kansè nan tete56 etid
- Kansè Poumon ki pa ti selil51 etid
- Kansè Metastatik46 etid
- Kansè pwostat44 etid
- Kansè kolorektal44 etid
- Kansè ovè44 etid
- Kansè poumon36 etid
- Leksemi mieloïd egi34 etid
- Ensifizyans kadyak31 etid
- Kansè Endomèt28 etid
- Depresyon26 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.